Singapore markets open in 4 hours 49 minutes
Straits Times Index
3,296.89 +4.20 (+0.13%) S&P 500
5,064.20 +45.81 (+0.91%) Dow
38,225.66 +322.37 (+0.85%) Nasdaq
15,840.96 +235.48 (+1.51%) Bitcoin USD
59,233.10 +2,018.29 (+3.53%) CMC Crypto 200
1,277.75 +7.01 (+0.55%)
Mosaic ImmunoEngineering, Inc. (CPMV)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 10:50AM EDT
| Previous close | 0.6000 |
| Open | 0.6000 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 0.6000 - 0.6000 |
| 52-week range | 0.3020 - 1.0000 |
| Volume | |
| Avg. volume | 506 |
| Market cap | 4.345M |
| Beta (5Y monthly) | -1.43 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.1400 |
| Earnings date | 12 May 2024 - 16 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 02 Mar 2007 |
| 1y target est | N/A |
GlobeNewswireOncotelic Therapeutics, Inc. to Sell Its Necroptosis Cancer Therapy Assets to Mosaic ImmunoEngineering, Inc.
AGOURA HILLS, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB:OTLC) ("Oncotelic", the "Company" or "We" or “Our”), announced today that it has entered into a binding term-sheet with Mosaic ImmunoEngineering, Inc. (OTCPK: CPMV) (“Mosaic”) under which Mosaic will acquire rights to Oncotelic’s clinical-stage necroptosis cancer therapies. Oncotelic’s necroptosis therapeutics work by disrupting tumor blood flow resulting in immunogenic tumor cell death through “death re
© 2024 Yahoo. All rights reserved.